What happens when a multiplex qPCR assay begins to lose perf...
Read More Optimizing multiplex qPCR: How to amplify up to 6 targets without compromising sensitivity

What happens when a multiplex qPCR assay begins to lose perf... by Behind The Bench Staff / 04.01.2026
Read More Optimizing multiplex qPCR: How to amplify up to 6 targets without compromising sensitivity
Overview Scale-up challenges in pharmaceutical manufacturi... Dirk Leister by / 03.31.2026
Read More Geometry-Dependent vs Parameter-Driven Scale Up in Pharmaceutical ManufacturingÂ
Scientific, joins the Absolute Gene-ius podcast to discuss h... by Behind The Bench Staff / 03.24.2026
Read More From Discovery to Monitoring: How Sequencing and PCR Work Together in Oncology Research
In this first Absolute Gene-ius: Science Snapshot episode, h... by Behind The Bench Staff / 03.24.2026
Read More When PCR Gets Dirty – Tackling PCR Inhibitors
Overview Predictable scale-up in pharmaceutical extrusion ... Dirk Leister by / 03.17.2026
Read More Designing for Predictable Scale-Up in Pharmaceutical ExtrusionÂ
As fragmentomics gains momentum in cancer liquid biopsy rese... Deepak Tripathi, PhD by / 03.05.2026
Read More qPCR-based fragmentomics for monitoring cancer disease progression
On the Absolute Gene-ius podcast, Lexi Heger, PhD candidate ... by Behind The Bench Staff / 02.28.2026
Read More Tracking grape pathogens from air to vine – a conversation with Lexi Heger
In this episode of Absolute Gene-ius, we explore how digital... by Behind The Bench Staff / 02.27.2026
Read More Unlocking Cancer’s Genetic Secrets with Digital PCR
The United States National Institutes of Health has prioriti... by Behind The Bench Staff / 02.25.2026
Read More Scaling Human-Relevant Oncology Testing: OncoPro Tumoroids on ScreenIn3D’s UpScale Platform
Drug discovery capabilities continue to advance rapidly. Med... Dirk Leister by / 02.17.2026
Read More Why Most Modern Drug Candidates Fail at SolubilityÂ